Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (4) , 1292-1294
- https://doi.org/10.1016/s0041-1345(98)00246-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- HYPERLIPIDEMIA IN SOLID ORGAN TRANSPLANTATIONTransplantation, 1997
- TREATMENT OF HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1997
- Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506)Liver Transplantation and Surgery, 1997
- IMPACT OF SERUM LIPIDS ON LONG-TERM GRAFT AND PATIENT SURVIVAL AFTER RENAL TRANSPLANTATION1Transplantation, 1995
- ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIATransplantation, 1995
- THE EFFECTS OF PRAVASTATIN ON HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1992
- Cyclosporine, Low-Density Lipoprotein, and CholesterolMayo Clinic Proceedings, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988